Testicular cancer
Around 2,100 men are diagnosed with testicular cancer every year in the UK, and rates are rising. But treatment for testicular cancer is very effective and nearly all men are cured of the disease.
Testicular cancer is more common in younger and middle-aged men than it is in older men. One risk factor for testicular cancer is having undescended testicle , when one or both testicles have not moved down into the scrotum. If this is not corrected in childhood then the risk of testicular cancer is increased.
Cancer Research UK funds research into all aspects of testicular cancer. Our research helped to develop a drug called cisplatin, which is now used to treat the disease. We are also funding scientists working to understand the genetic causes of testicular cancer.
Browse content about Testicular cancer
Most recent news and press releases about Testicular cancer
- News story: UK scientists identify first testicular cancer risk genes
31 May 2009 - Press Release: New chemotherapy 'cures' early testicular cancer
6 October 2008 - News story: Testicular cancer feels the heat
26 July 2006 - Press Release: Testicular trial puts PET scanner to the test
26 June 2002
- News story: "More research needed" over testicular cancer cannabis link
10 February 2009 - News story: UK testicular cancer awareness highest in EU says study
23 November 2006 - Press Release: Fertility boost for testicular cancer patients
19 July 2005 - Press Release: World Cup warning for top teams' tackle
6 June 2002
Increase text
Decrease text
Print this page